Coronary angiography following acute myocardial infarction in Ontario, Canada

Archives of Internal Medicine

Volumn 167, Issue 8, 2007, Pages 808-813

  Singh, Sheldon M ^a   Austin, Peter C ^b,c   Chong, Alice ^c   Alter, David A ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEALTH CARE FACILITY; HEART CATHETERIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; CORONARY ANGIOGRAPHY; HEART CATHETERIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL INFARCTION; ONTARIO; RANDOMIZED CONTROLLED TRIALS;

EID: 34247489687     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.8.808     Document Type: Article

References (28)

1. Every NR, Larson EB, Litwin PE, et al. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med. 1993;329:546-551.
2. Khaykin Y, Austin PC, Tu JV, Alter DA. Utilisation of coronary angiography after acute myocardial infarction in Ontario over time: have referral patterns changed? Heart. 2002;88:460-466.
3. Alter DA, Stukel TA, Newman A. Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare. Circulation. 2006;113:380-387.
4. Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE. Temporal trends in the diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001. Circulation. 2006;113:374-379.
5. Ayanian JZ. Rising rates of cardiac procedures in the United States and Canada: too much of a good thing? Circulation. 2006;113:333-335.
6. Fu Y, Chang WC, Mark DB, et al. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Circulation. 2000;102:1375-1381.
7. Alter DA, Naylor CD, Austin PC, Tu JV. Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA. 2001;285:2101-2108.
8. Stukel TA, Lucas FL, Wennberg DE. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare patients with acute myocardial infarction. JAMA. 2005;293:1329-1337.
9. Yusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet. 1998;352:507-514.
10. Cardiac Care Network of Ontario Consensus panel on target setting: final report and recommendations. 2004. http://www.ccn.on.ca/pdfs/ Cons_Panel_Target _Setting_FRR.pdf. Accessed September 17, 2006.
11. Batchelor WB, Peterson ED, Mark DB, et al. A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. J Am Coll Cardiol. 1999;34:12-19.
12. Graham MM, Ghali WA, Faris PD, et al. Population rates of cardiac catheterization rates and yield of high risk coronary artery disease. CMAJ. 2005;173:35-39.
13. Omoigui NA, Silver MJ, Rybicki LA, et al. Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVET). J Am Coll Cardiol. 1998;31:265-272.
14. Tu JV, Naylor CD, Austin P. Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ. 1999;161:1257-1261.
15. Tu JV, Austin PC, Walld R, Roos L, Agras J, McDonald KM. Development and validation of acute myocardial infarction prediction rules. J Am Coll Cardiol. 2001;37:992-997.
16. Toma M, McAlister FA, Bialy L, Adams D, Vandermeer B, Armstrong PW. Transition from meeting abstract to full-length journal article for randomised controlled trials. JAMA. 2006;295:1281-1287.
17. Barry D, Hartigan JA. A Bayesian analysis for change point problems. J Am Stat Assoc. 1993;88:309-319.
18. Gilks WR, Richardson S, Spiegelhalter DJ. Introducing Markov Chain Monte Carlo. In: Gilks WR, Richardson S, Spiegelhalter DJ, eds. Markov Chain Monte Carlo in Practice. London, England: Chapman & Hall; 1996:1-19.
19. Geweke J. Evaluating the accuracy of sampling-based approaches to calculating posterior moments. In: Bernardo JM, Berger JO, Dawid AP, Smith AFM, eds. Bayesian Statistics 4. Oxford, England: Clarendon Press; 1994:169-193.
20. Fragmin and Fast Revascularization during In Stability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;354:708-715.
21. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
22. Fowler RA, Cook DJ. The arc of the pulmonary catheter. JAMA. 2003;290:2732-2734.
23. Weiner DK, Kim YS, Bonino P, Wang T. Low back pain in older adults: are we utilizing health care resources wisely. Pain Med. 2006;7:143-150.
24. Cook DJ, Sibbald WJ. The promise and the paradox of technology in the intensive care unit. CMAJ. 1999;161:1118-1119.
25. Cassell EJ. The sorcerer's broom: medicine's rampant technology. Hastings Cent Rep. 1993;23:32-39.
26. Grimes DA. Technology follies: the uncritical acceptance of medical innovation. JAMA. 1993;269:3030-3033.
27. Majumdar SR, Chang WC, Armstrong PW. Do the investigative sites that take part in a positive clinical trial translate that evidence into practice? Am J Med. 2002;113:140-145.
28. Manuel DG, Kwong K, Tanuseputro P, et al. Effectiveness and efficiency of different guidelines on statin treatment for preventing coronary heart disease: modelling study. BMJ. 2006;332:1419-1423.